And whilst I say 8-10x is more suitable for a growth stock, you'll find significantly higher multiples often applied for quality growing companies, particularly in the healthcare and tech space. The rerate to a higher valuation multiple alone (not accounting for any actual growth in revenue/earnings) should be quite spectacular when it does arrive. Seems to be an appealing opportunity for both the value investor and the growth investor![]()
Now we just need the numbers to be announced to confirm the conclusions we have made as a result of our observation of industry news-flow and company social media updates!
- Forums
- ASX - By Stock
- EYE
- Nova Eye Medical (EYE) Discussion
Nova Eye Medical (EYE) Discussion, page-2697
-
-
- There are more pages in this discussion • 491 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 63999 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 97558 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 63999 | 0.210 |
1 | 73170 | 0.205 |
14 | 251694 | 0.200 |
3 | 119489 | 0.195 |
2 | 58636 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 97558 | 1 |
0.220 | 107010 | 2 |
0.225 | 45409 | 3 |
0.230 | 103718 | 2 |
0.235 | 20000 | 1 |
Last trade - 10.02am 03/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
Day chart unavailable